Colony Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
Colony Group's BSX Position: Q3 2023 in Review
Colony Group reduced its Boston Scientific (BSX) stake by 1.3% in Q3 2023, selling an estimated $7.03K and leaving 10,175 shares worth $537K. The position accounts for 0.01% of the portfolio, ranked #537.
Colony Group first reported a position in BSX in Q1 2014 and has held it in 19 quarters since. The position peaked at $924K in Q4 2022. 1,057 funds tracked by Wall St. Rank hold BSX as of Q3 2023.
- Colony Group held 10,175 shares of Boston Scientific worth $537K as of Q3 2023.
- Colony Group sold 134 Boston Scientific shares in Q3 2023, an estimated $7.03K.
- Boston Scientific made up 0.01% of Colony Group's portfolio in Q3 2023, its #537 holding.
- Colony Group first reported a position in Boston Scientific in Q1 2014 and has held it in 19 quarters since.
- Colony Group's Boston Scientific position peaked at $924K in Q4 2022.
- 1,057 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2023.
Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.